Why Does My Patient Have Thrombocytosis?

Sep 16, 2017 by in HEMATOLOGY Comments Off on Why Does My Patient Have Thrombocytosis?

Thrombocytosis is a common clinical problem frequently encountered during routine evaluation. The diagnostic workup entails a step-by-step approach, which allows for an accurate assessment of the underlying cause. A thorough…

read more

Why Does My Patient Have Erythrocytosis?

Sep 16, 2017 by in HEMATOLOGY Comments Off on Why Does My Patient Have Erythrocytosis?

Primary polycythemias are the result of intrinsic abnormalities of the hematopoietic progenitors that lead to constitutive overproduction of red cells accompanied by low erythropoietin (EPO) levels. Secondary polycythemias are caused…

read more

Why is My Patient Neutropenic?

Sep 16, 2017 by in HEMATOLOGY Comments Off on Why is My Patient Neutropenic?

Neutropenia is a common reason for hematology consultations in the inpatient and outpatient settings and is defined as an absolute neutrophil count less than 1500 cells/μL. Neutropenia varies in severity,…

read more

Why is My Patient Anemic?

Sep 16, 2017 by in HEMATOLOGY Comments Off on Why is My Patient Anemic?

Anemia is a decreased number of circulating red blood cells and is a common medical condition faced in clinical practice. Anemia is caused by loss of red blood cells, destruction…

read more

The Antifolates

Sep 16, 2017 by in HEMATOLOGY Comments Off on The Antifolates

This article focuses on the cellular, biochemical, and molecular pharmacology of antifolates and how a basic understanding of the mechanism of action of methotrexate, its cytotoxic determinants, mechanisms of resistance,…

read more

Antimitotic Inhibitors

Sep 16, 2017 by in HEMATOLOGY Comments Off on Antimitotic Inhibitors

Of the agents available in the treatment of both solid and hematologic cancers, microtubule-targeted agents are among the most widely used and exploiting other mechanisms involving the microtubule and its…

read more

Tyrosine Kinase Inhibitors in Lung Cancer

Sep 16, 2017 by in HEMATOLOGY Comments Off on Tyrosine Kinase Inhibitors in Lung Cancer

Identification of driver mutations in growth related protein kinases, especially tyrosine kinases, has led to clinical development of an array of tyrosine kinase inhibitors in various malignancies, including lung cancer….

read more

Targeting the Hedgehog Pathway

Sep 16, 2017 by in HEMATOLOGY Comments Off on Targeting the Hedgehog Pathway

The Hedgehog (Hh) pathway is a signaling cascade that is evolutionally highly conserved and plays an important role in embryonic pattern formation and stem cell response to tissue damage. Given…

read more
Get Clinical Tree app for offline access